The IMPACT Study - Single Inhaler Triple Therapy (FF/UMEC/VI) Versus FF/VI And UMEC/VI In Patients With COPD: Efficacy And Safety In A Japanese Population.

Motokazu Kato Keisuke TomiiKenichi HashimotoYasuko NezuTakeo IshiiC Elaine JonesSally KilbrideAnnette S GrossChristine S CliftonDavid A Lipson

Published in: International journal of chronic obstructive pulmonary disease (2019)

These results highlight the favorable benefit-risk profile of FF/UMEC/VI single-inhaler triple therapy compared with FF/VI or UMEC/VI dual therapy in patients in Japan with symptomatic COPD and ≥1 exacerbation in the prior year.

Keyphrases

chronic obstructive pulmonary disease
lung function
stem cells
intensive care unit
cystic fibrosis
bone marrow
extracorporeal membrane oxygenation
mechanical ventilation